title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
AC Immune  ( ACIU )  Surges 43% in the Past 3 Months: Here's Why,20230905T170900,https://www.zacks.com/stock/news/2145026/ac-immune-aciu-surges-43-in-the-past-3-months-heres-why,ANVS,0.293214,Neutral,-0.028422
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win - Biogen  ( NASDAQ:BIIB ) ,20220928T201722,https://www.benzinga.com/general/biotech/22/09/29061026/these-stocks-are-on-the-radar-after-biogen-eisais-surprising-alzheimers-trial-win,ANVS,0.112269,Neutral,0.0
Stocks That Hit 52-Week Lows On Thursday,20220428T193101,https://www.benzinga.com/markets/options/22/04/26872967/52-weeks-high-and-low-article,ANVS,0.00644,Neutral,0.009011
Annexon  ( ANNX )  Up as Phase III Neuro Disorder Study Meets Goals,20240605T145700,https://www.zacks.com/stock/news/2284172/annexon-annx-up-as-phase-iii-neuro-disorder-study-meets-goals,ANVS,0.180124,Neutral,-0.025698
InflaRx  ( IFRX )  Skyrockets 110% in Six Months: Here's Why,20230901T183800,https://www.zacks.com/stock/news/2143927/inflarx-ifrx-skyrockets-110-in-six-months-heres-why,ANVS,0.236972,Neutral,0.064178
Stocks That Hit 52-Week Lows On Tuesday,20220426T174457,https://www.benzinga.com/markets/options/22/04/26818122/52-weeks-high-and-low-article,ANVS,0.00928,Somewhat-Bearish,-0.314577
50 Stocks Moving In Wednesday's Mid-Day Session,20220608T162921,https://www.benzinga.com/news/22/06/27612909/50-stocks-moving-in-wednesdays-mid-day-session,ANVS,0.083701,Neutral,0.00149
"Advanced Human Imaging  ( NASDAQ:AHI ) , Aditxt  ( NASDAQ:ADTX )  - Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday",20220912T072340,https://www.benzinga.com/news/22/09/28823434/why-immunocore-shares-dipped-22-here-are-73-biggest-movers-from-friday,ANVS,0.062597,Neutral,0.0
UniQure Soars on New Huntington's Disease Study Data,20240710T205623,https://markets.businessinsider.com/news/stocks/uniqure-soars-on-new-huntington-s-disease-study-data-1033544723,ANVS,0.12165,Neutral,-0.050108
uniQure  ( QURE )  Soars on New Huntington's Disease Study Data,20240710T130100,https://www.zacks.com/stock/news/2299274/uniqure-qure-soars-on-new-huntingtons-disease-study-data,ANVS,0.156207,Neutral,-0.010969
"Stocks That Hit 52-Week Lows On Wednesday - Bristol-Myers Squibb Company Common Stock  ( NYSE:BMY ) , SenesTech, Inc. - Common Stock  ( NASDAQ:SNES ) ",20231004T160117,https://www.benzinga.com/markets/options/23/10/35092508/stocks-that-hit-52-week-lows-on-wednesday,ANVS,0.012708,Neutral,0.004414
New Strong Buy Stocks for April 18th,20230418T122200,https://www.zacks.com/commentary/2079483/new-strong-buy-stocks-for-april-18th,ANVS,0.535653,Neutral,0.0
Bio-Path  ( BPTH )  Rises on Upbeat Updates From Blood Cancer Study,20240419T141400,https://www.zacks.com/stock/news/2258537/bio-path-bpth-rises-on-upbeat-updates-from-blood-cancer-study,ANVS,0.231332,Neutral,-0.027341
Medical Second Opinion Global Market to Register Stunning Growth at a CAGR of ~17% by 2028 | DelveInsight,20230821T210100,https://www.prnewswire.com/news-releases/medical-second-opinion-global-market-to-register-stunning-growth-at-a-cagr-of-17-by-2028--delveinsight-301905294.html,ANVS,0.024347,Neutral,0.051825
"Dementia Market to Grow Rapidly, Estimates DelveInsight | Key Companies Active in the Market - Pfizer, Eli Lilly and Company, Janssen, Merck, BioVie, Biogen, Vivoryon, Sage, Alnylam, BioXcel, EIP, Otsuka, Alector, Transposon",20230726T210100,https://www.prnewswire.com/news-releases/dementia-market-to-grow-rapidly-estimates-delveinsight--key-companies-active-in-the-market---pfizer-eli-lilly-and-company-janssen-merck-biovie-biogen-vivoryon-sage-alnylam-bioxcel-eip-otsuka-alector-transposon-301885979.html,ANVS,0.047607,Neutral,0.049275
"COYA, Dr. Reddy's Sign Deal for Proposed Abatacept Biosimilar",20230321T152400,https://www.zacks.com/stock/news/2068596/coya-dr-reddys-sign-deal-for-proposed-abatacept-biosimilar,ANVS,0.234307,Neutral,0.064555
Annovis Bio  ( ANVS )  Stock Surges 38% in a Month: Here's Why,20231201T161200,https://www.zacks.com/stock/news/2192301/annovis-bio-anvs-stock-surges-38-in-a-month-heres-why,ANVS,0.324902,Neutral,0.006998
"Blueprint  ( BPMC )  Q1 Earnings and Revenues Beat, Stock Rises",20240503T135100,https://www.zacks.com/stock/news/2268056/blueprint-bpmc-q1-earnings-and-revenues-beat-stock-rises,ANVS,0.210823,Neutral,-0.025387
83 Biggest Movers From Yesterday,20220609T094429,https://www.benzinga.com/news/22/06/27622472/83-biggest-movers-from-yesterday,ANVS,0.050572,Neutral,0.005222
